Arie and Dan Belldegrun are building biotech campuses around the globe — with a newly raised $3B fund to keep the dirt flying
The biotech sector on Nasdaq may have been blighted by imploding stock prices, the generalists long gone in search of greener fields as the bears rule the once booming industry. But while the emphasis inside many biotechs now may be more about conserving cash in the bank than raising money or expanding the pipeline, fresh billions are still rolling into the industry — only this time the money is coming from a lineup of sovereign wealth funds and other global players getting behind a record-setting life science real estate fund that’s the brainchild of Kite founder Arie Belldegrun and his son Dan.
Premium subscription required
Unlock this article along with other benefits by subscribing to one of our paid plans.